Fierce Pharma

Halozyme is putting a recent drug-delivery acquisition to work thanks [...]

The FDA is seeking new powers to hold companies accountable [...]

In response to a warning letter from the FDA that [...]

A recent episode of ABC’s Scrubs featured an on-screen brand [...]

Neurocrine Biosciences, forever a possible M&A target in the biopharma [...]

Where does pharma’s reshoring push stand today, and what comes [...]

The U.S. will impose a 100% tariff on drug imports [...]

The president has rolled out a 100% tariff rate on [...]

The U.K.’s end of the deal requires it to spend [...]

BioNTech is turning out the lights at the Singapore plant [...]